bioAffinity Technologies, Inc. (BIAF )

Currency in USD Disclaimer
$5.29 +$1.88 (55.13%)
Closed 09/26/2025
$4.65
$7.29
$3.4
$67.11

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol BIAF
  • Company bioAffinity Technologies, Inc.
  • Price $5.29
  • Changes Percentage 55.13
  • Change 1.88
  • Day Low $4.65
  • Day High $7.29
  • Year High $67.11
  • Year Low $3.4
  • Market Cap $4,967,247
  • Price Avg 50 EMA (D) $7.86
  • Price Avg 200 EMA (D) $13.9
  • Exchange NASDAQ
  • Volume 99,562,135
  • Average Volume 1,767,427
  • Open $6.2
  • Previous Close $3.41
  • EPS -26.53
  • PE -0.20
  • Earnings Announcement 2025-11-12 12:00:00
  • Shares Outstanding $938,988

Company brief: BIOAFFINITY TECHNOLOGIES, INC. (BIAF )

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

BIAF Corporation News

bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung

bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung

September 26, 2025 at 12:00 pm ET

businesswire.com -- SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies shares 3 new case studies in which CyPath Lung detected Stage 1A lung cancer or prevented unnecessary invasive procedures....

Income Statement